CytomX Therapeutics, Inc.
Recent Filings
All 762 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| McCarthy Sean A. | CEO | Sale | 101,793 @ $4.54 | 987,891 | Nov 6, 2025 |
| Ogden Christopher | Chief Financial Officer | Sale | 1,641 @ $2.95 | 199,385 | Jun 13, 2025 |
| BELVIN MARCIA | SVP, Chief Scientific Officer | Sale | 13,884 @ $2.69 | 272,252 | Jun 13, 2025 |
| McCarthy Sean A. | CEO | Sale | 37,656 @ $0.60 | 995,195 | Mar 18, 2025 |
| Ogden Christopher | Chief Financial Officer | Sale | 8,551 @ $0.60 | 201,026 | Mar 18, 2025 |
| Chu Yu-Waye | Chief Medical Officer | Sale | 4,025 @ $0.60 | 135,725 | Mar 18, 2025 |
| ROWLAND LLOYD A | General Counsel | Sale | 10,203 @ $0.60 | 120,594 | Mar 18, 2025 |
| BELVIN MARCIA | SVP, Chief Scientific Officer | Sale | 19,512 @ $0.60 | 248,636 | Mar 18, 2025 |
| BELVIN MARCIA | SVP, Chief Scientific Officer | Award / Grant | 35,000 | 210,648 | Feb 4, 2025 |
| BELVIN MARCIA | SVP, Chief Scientific Officer | Award / Grant | 57,500 | 263,148 | Feb 4, 2025 |